Approach to Peripheral Neuropathy
Approach to Peripheral Neuropathy.
Determine if there is a problem with the PNS vs CNS
Check if there is the presence of UMN signs, if so it is of central etiology
Hyporeflexia in a symptomatic limb suggests a peripheral lesion, whereas brisk reflexes in a symptomatic limb suggest a central cause.
UMN + LMN - central. ConsiderMND - AHC.
Pain in the distribution of nerves is PNS. Not a prominent feature of CNS
Lesions in the brain and brainstem rarely cause pain. A notable exception is central poststroke pain. This is a rare late effect of ischemic stroke, usually in the thalamus, and is characterized by contralateral hyperalgesia and allodynia. The presence of pain with neuropathic features (eg, burning, tingling, electric shock–like sensation) in the affected limb(s) should prompt the examiner to consider a peripheral etiology.
Focal or multifocal: PNS vs CNS
Hemiparesis and hemianesthesia include face (Hemibody): CNS. If all the signs and symptoms are in a single limb, both central and peripheral localizations are possible. Hemibody symptoms suggest a central localization; no single lesion in the peripheral nervous system can cause isolated symptoms affecting an arm and leg on the same side of the body.
If a patient has deficits in both strength and pain/temperature sensation in the same limb and no other abnormalities, the lesion is either in the brain or the peripheral nervous system, not in the spinal cord.
Patients with ascending sensory loss in both lower extremities may have either a spinal cord lesion or a polyneuropathy. Peripheral polyneuropathy causes length-dependent symptoms and signs, so by the time the sensory loss spreads up above the knee, the distal upper extremities are usually involved as well. Sensory loss that spreads up from the feet to the groin or trunk without any upper extremity involvement is almost always related to spinal cord pathology. Check for pattern of stocking and glove (favors PNS)
Patients with upper extremity weakness due to a CNS lesion often have preferential involvement of the extensors, such as the triceps and wrist and finger extensor muscles. Although rare, a proximal radial mononeuropathy could also affect these muscles. To rule that out, it is useful to test the strength of the brachioradialis, which will be reduced in a proximal radial mononeuropathy but relatively spared (along with the other upper extremity flexors) in a CNS lesion. Patients with leg weakness due to a CNS lesion often have preferential weakness of the flexors, such as the iliopsoas, hamstrings, and tibialis anterior. No single peripheral lesion could affect all of these muscles in isolation.
Confirm the presence of a peripheral neuropathy
Localization in peripheral nervous system
Root, plexus, peripheral nerve (single, multiple, diffusely), NMJ, or muscle.
Symptoms
Large fiber sx
Small fiber sx
Use of SW monofilament (10 g) test to for loss of protective sensation (LOPS)
Sensory:
Positive symptoms
Large fiber: Tingling, pins-needles
Small fiber: Burning, electric shocks, sharp jabbing pain, icepick pain and creepy crawly sensation, sparks
Negative symptoms
Large fiber: Decreased vibration, touch, and joint position sensations, , socks bunched up under toes and ball of feet. ataxia, hyporeflexia, areflexia, hypotonia.
Small fiber: Decreased pain, burning, and temperature sensation.
Paresthesias are abnormal spontaneous sensations in the absence of specific stimulation: Feelings of cold, warmth, numbness, tingling, crawling, heaviness, compression, and itching.
Dysesthesias are distorted, usually pain or electric sensations after tactile or painful stimulation.
Allodynia is burning, loss of temperature sensation: small fiber.
Descriptors : "Band-like, wrapped in plastic, swollen, or wooden sensation, cotton stuffed between toes, skin covered with dried glue", sensory ataxia, nocturnal balance is precarious as is balance in shower while hair washing: large fiber.
Motor:
Negative sx: Weakness, fatigue, hypotonia, gait instability, hyporeflexia/areflexia
Positive sx: Cramps in distal legs, stiffness, fasciculations, tics, myoclonus, myokymia, or other adventitious muscle movements. Foot drop and frequent falls.
Settings in which symptom onset occurred, evolved chronologically.
Sensory sx usually precede motor sx.
Neuropathic pain will often worsen at night and impair sleep.
Findings of motor involvement that precede or are out of proportion to sensory findings should alert the examiner to the possibility of motor neuron disease or multifocal motor neuropathy, although motor involvement can be appreciated in more chronically progressive genetic neuropathies (eg, Charcot-Marie-Tooth disease).
Autonomic sx:
Resting tachycardia, palpitations, exercise intolerance, orthostatic hypotension, hypohidrosis/hyperhidrosis, postprandial nausea, early satiety, gastroparesis, constipation, diarrhea, urinary retention, blurred vision, photophobia, erectile dysfunction, sicca symptoms (dry eyes, dry mouth, vaginal dryness in women), loss of beat-to-beat variability in heart rate with deep breathing. Skin changes (loss of distal autonomic-vasomotor control) such as hair loss, shiny skin, dry, and atrophic skin. Cold or too warm. Erythematous or blanche color changes. Dystrophic nails. Cracked skin about the heels. Lack of pedal sweating (dry socks). Lack of sweating in axilla and groin region. Dry eyes and dry mouth.
Differentiate from myopathy:
Distal weakness in neuropathy, proximal in myopathy.
Distal weakness.
Patients complain of problems buttoning shirt, picking coins of table, zipping pants, opening pill bottles, jar tops, door knobs in distal weakness
Proximal weakness.
Patients complain of problems reaching overhead, putting or taking things off overhead shelf, combing or shampooing hair, brushing teeth, getting off the toilet seat, low chair, ascending or descending the stairs.
Upper extremity weakness - functional query
Shoulder girdle weakness/abduction: unable to reach overhead, washing hair, combing hair, getting arms in sleeves of clothing, getting objects from shelves.
Elbow flexion/extension: unable to open doors by pulling or pushing door handle/knobs, respectively.
Wrist and digit weakness: affects dexterity of hand. Problems buttoning shirt, picking coins of table, zipping pants, opening pill bottles, jar tops, door knobs, turning keys.
Shoulder drop: trapezius weakness.
Winged scapula
Lower extremity weakness - functional query
Hip flexion: difficulty getting in and out of the car without lifting legs; difficulty going upstairs
Hip abduction: waddling gait
Hip extension: exaggerated lumbar lordosis
Knee extension: difficulty getting up from a deep sofas or chairs, toilet seat, from a squat. History of falls due to knee buckling. Compensatory posture of limb in genu recurvatum.
Ankle dorsiflexion: unable to walk on heels, scuffing of forefoot leading to trips and falls.
Ankle plantar-flexion: unable to tip-toe walk
Cranial neuropathies are seen in some peripheral nerve disorders, primarily those with a multifocal or non–length-dependent anatomic distribution. Facial strength and eye movement are frequently affected in GBS. Tongue and oropharyngeal weakness are common in motor neuron disease. Tonic pupils may be suggestive of dysautonomia.
EOM are not (rarely) affected in MND or acquired inflammatory myopathies. Affected in inflammatory demyelinating polyneuropathies, DNMT, mitochondrial myopathies, dystrophies, congenital myopathies, thyroid diseases, and diabetes.
Bulbar weakness: face, chewing, swallowing, salivation, speech. Difficulty manipulating food in mouth while chewing.
Weakness of neck muscles: head-drop, neck soreness/pain.
Respiratory: hyoventilation, sleep apnea, day-time somnolence, excessive daytime fatigue. Nocturnal restlessness (due to nocturnal hypocarbia), RLS. Orthopnea.
Cardiac: CM, conduction abnormalities
GI: dysphagia, impaired GI motility, constipation, porphyria
Renal: myoglobinuria
Skin: rashes. Porphyria
Delayed developmental milestones: Late walker (>15 months), clumsiness, frequent falls, ankle sprains, inability to keep up with peers in athletics and sports; avoidance of physical education at school.
What is the temporal course and progression of the polyneuropathy (confirmed by history and EDX studies)
Acute: Nadir within 4 weeks after onset.
Subacute: Progressive course lasting up to a maximum of 8 weeks.
Motor neuron: Acute flaccid paralysis, paraneoplastic.
Spinal root: Disk herniation, varicella-zoster virus.
Sensory neuron: Paraneoplastic, Sjögren syndrome, pyridoxine toxicity.
Plexus: Idiopathic neuralgic amyotrophy, diabetic lumbosacral radiculoplexus neuropathy (DLRPN).
Nerve: Direct nerve trauma, toxic (eg, chemotherapy or heavy metal-induced), vasculitic mononeuritis multiplex, acute inflammatory demyelinating polyradiculoneuropathy (AIDP) and variants.
Neuromuscular junction: Botulism.
Muscle: Inflammatory myopathies, rhabdomyolysis due to a metabolic myopathy, toxic myopathies.
Chronic progressive: Progression continuing after 8 weeks.
Monophasic: one single disease period.
Relapsing and remitting: Periods of worsening and improvement.
Acute polyneuropathies are less common
GBS (AIDP)
Treatment induced neuropathy of DM (acute)
Chronic
CIDP, paraproteinemic neuropathies
idiopathic small fiber neuropathy
Progression: rapidly progressive, stepwise, relapsing/remitting, slowly progressive.
Rapidly progressive: GBS
Stepwise: mononeuropathy multiplex
Relapsing remitting course
Unusual and if present suggests intermittent exposure/intoxication or a variant of CIDP
Slowly progressive: inherited (CMT)
Anatomical pattern of neuropathy: (determined by physical exam and EDX studies). Examine patient with adequate exposure (gowned patient). Never examine a fully clothed patient in neuromuscular clinics.
Examine exposed body parts: facial dysmorphism, muscle atrophy, hypertrophy, fasciculations, myokymia, pes cavus, pes planus, winged scapula, shoulder drop, kyphoscoliosis, levoscoliosis, hyperlordosis, genu recurvatum genu valgus, genu varus, gynecomastia, atrophy or median furrowing of tongue, tongue fasiciculations, rash of dermatomyositis, cafe-au-lait spots, neurofibroma, and other neurcutaneous stigmata.
Is it multifocal or generalized?
Distal to proximal (length-dependent)
Stocking, glove distribution
Distal predominant polyneuropathy
Symmetric, asymmetrical
A symmetric and distal (ie, length-dependent, stocking-glove) distribution of sensorimotor symptoms is classically associated with genetic, toxic, and metabolic polyneuropathies. This pattern indicates a systemic etiology that affects the more metabolically vulnerable distal nerves.
Asymmetrical pattern if present will exclude toxic, metabolic, and inherited neuropathies (these cause only a symmetric pattern). Asymmetry implies mononeuropathy multiplex pattern, superimposed radiculopathy or entrapment neuropathy, or a variant of CIDP. A monomelic distribution of sensorimotor symptoms can suggest a focal neuropathic process including compressive mononeuropathies, isolated radiculopathies, or rarely autoimmune conditions that impact the brachial and lumbosacral plexuses such as cervical or lumbosacral radiculoplexus neuropathy, multifocal motor neuropathy, or multifocal CIDP.
A patchy distribution (ie, multifocal, non–length dependent) that is asymmetric and involves both proximal limb regions along with the face and trunk can suggest autoimmune neuropathies (eg, vasculitic neuropathies, sensory neuronopathies, acquired demyelinating neuropathies) where seemingly random segments of nerve root and peripheral nerve are “picked off” one by one
Non-length dependent pattern (face, trunk, arms).
Autoimmune diseases: Sjogren's syndrome, celiac disease, sacroidosis, and paraneoplastic syndromes
DM, IGT, Vit B12 deficiency, paraproteinemias, porphyria, fibromyalgia.
Pattern recognition:
NP1: symmetric proximal and distal weakness with sensory loss: CIDP, GBS
NP2: symmetric distal sensory loss with or without weakness (distal symmetric polyneuropathy): CSPN (cryptogenic sensory polyneuropathy), diabetic neuropathy, alcohol neuropathy, toxic neuropathies, paraproteinemias, DADS-M , idiopathic polyneuropathy, amyloid, HSN, CMT
NP3: asymmetric distal weakness with sensory loss (mononeuropathy mulitplex):
Single nerves/roots: compressive neuropathy, radiculopathies.
Multiple nerves: Vasculitis, HNPP, sarcoidosis, infection (HIV, CMV, HZV, lyme disease, leprosy, hepatitis), MADSAM, multifocal CIDP.
NP4: asymmetric proximal and distal weakness with sensory loss: polyradiculopathy, plexopathy, HNPP, DLRPN, Parsonage-Turner syndrome, meningeal disorders, such as carcinoma, lymphoma, sarcoidosis, or infections, which may infiltrate multiple nerves, roots, and regions of the plexus.
NP5: asymmetric distal weakness without sensory loss: MND (ALS), MMN, WNV, post-polio syndrome.
NP6: symmetric sensory loss with or without weakness, and UMN: combined system degeneration (vit B12, copper def.), adrenomyeloneuropathy, metachromatic leukodystrophy, Friedreich's, cervical spondylosis.
NP7: symmetric weakness without sensory loss:
Proximal and distal: SMA
Distal: distal SMA, CMT (sensory signs will be present).
Overlap pattern with myopathy/NMJ d/o
NP8: focal midline proximal symmetric weakness
Neck or trunk extensor weakness: ALS, overlap pattern (MG, INEM a.k.a isolated neck-extensor myopathy), ITEM,
Bulbar weakness: ALS/PLS, isolated bulbar ALS (IBALS), Kennedy's syndrome, X-linked bulbo-spinal SMA, overlap pattern (MG, OPD)
Diaphragm: ALS, overlap (MG, Pompe)
NP9: Asymmetric proprioceptive loss without weakness: CISP, paraneoplastic, Sjogren's synd., vitamin B6 toxicity, cisplatin, HIV, idiopathic, vitamin E deficiency.
NP10: Neuropathies with significant autonomic dysfunction: DM, GBS, amyloidosis (familial and acquired), PAF, porphyria, HIV related autonomic neuropathy, idiopathic pandysautonomia, HSAN, paraneoplastic, Sjogren's synd.,
Example: Diabetic sensory polyneuropathy is an acquired, chronic, slowly progressive, length-dependent, sensory-predominant, mixed large and small fiber, primarily axonal polyneuropathy with common concomitant dysautonomia associated with a history of diabetes.
Applying the same template as above with sufficient history, examination, and testing, every peripheral nerve disorder can be described within a similar framework with components of onset, pace of progression, anatomic distribution and pattern, modalities affected, affected nerve fiber type, electrodiagnostic features, and associated clinical context.
5. Pathology:
Axonal
demyelination
acquired
inherited
Primary demyelination is suggestive when there is global areflexia, hypertrophic nerves, moderate-to-severe muscle weakness with relative preservation of muscle bulk, motor symptoms and signs more prominent than sensory ones.
mixed
6. Family history of polyneuropathy.
CMT account for the majority of inherited polyneuropathies.
Ask about every individual family member at least first degree relatives; 3 generations up and down; parents, siblings, children, maternal and paternal grandparents, aunts, and uncles.
Any difficulty in walking, funny-looking feet, anyone used AFOs, ankle braces, used a cane, walker or a wheelchair?
Thin limbs, winged scapula, claw hands, swallowing issues.
Any history of bad arthritis or orthopedic problems, foot surgeries?
Causes of death if known of any family members?
Photographs of family members with odd feet.
7. Inquiry should be made about preceding or concurrent associated medical conditions:
Behaviors:
Smoking: paraneoplastic
Excess alcohol consumption: toxic neuropathy, nutritonal, and vitamin deficiencies
High risk sexual activities: HIV, syphilis
Medications and vitamin B6: Toxic polyneuropathy
Nitrous oxide abuse (Whippits): Cobalamin deficiency
Cocaine use: vasculitic neuropathy
IVDU: HIV, Hepatitis-C, cryoglobulinemia
Strict vegan: Cobalamin deficiency
Organ system impairment:
Endocrine: DM, hypothyroid
Cancer: paraneoplastic
Anemia: lead, cobalamin deficiencies, pernicious anemia
Cardiac: amyloid, Refsum disease, Fabry disease
Lung: sarcoid
Kidney: amyloid, Fabry disease
Skin: Fabry disease, Refsum disease, connective tissue disease
Joints: connective tissue disease
GI
Chronic constipation: amyloid
IBD: CIDP
GU
Incontinence, impotence: amyloid
Hearing loss: Inherited neuropathies, Refsum disease
Visual loss: Refsum disease, Fabry disease, amyloid, diabetic, toxic
Association with painless injuries:
DM polyneuropathies
Amyloid neuropathy
HSAN
Tabes dorsalis
Lepromatous neuropathies
Integumentary (skin, hair, and nail) changes:
Ulcerations: HSAN, DM
Hypopigmentation: sarcoid, leprosy
Hyperpigmentation: POEMS, adrenomyeloneuropathy, cobalamin deficiency, eosinophilia-myalgia syndrome
Purpura: cryoglobulinemic neuropathy (vasculitis)
Livideo reticularis: cryoglobulinemic neuropathy (vasculitis)
Ichthyosis: Refsum disease
Angiokeratomas: Fabry disease
Vesicles and bullae: variegate porphyria
Alopecia: hypothyroid, SLE, thallium
Curly hair: GAN
Mee's lines: arsenic and thallium toxicity
White nails: POEMS
Clubbing: POEMS, paraneoplastic (lung cancer), neuropathy associated with pulmonary disease, neuropathy associated with cirrhosis, neuropathy associated with IBD
Oral, genital mucosal, tongue, and salivary gland changes:
Oral and genital ulcers: Behcet disease, AIDS
Hairy leukoplakia, Kaposi syndrome, lymphoma: AIDS
Xerostomia, xerosis or cutaneous sicca, vagnitis sicca: Sjogren's syndrome
Salivary gland swelling: Sjogren's syndrome, sarcoid
Bald tongue: Cobalamin deficient, vitamin B complex deficient
Enlarged orange tonsils: Tangier disease
Ocular findings associated with peripheral neuropathies:
Dry eyes: Sjogren's synd, gelosin amyloid, HSAN type 1
Scleritis: vasculitis, RA, and connective tissue disorders
Uvetis: sarcoid, Behcet's disease, RA, IBD
Corneal opacities: Fabry disease, gelosin amyloid (lattice dystrophy)
Vitreous opacities: TTR amyloid, Refsum disease
Cataracts: Fabry disease, Refsum disease
Lens subluxation: Refsum disease
Optic atrophy: Refsum disease, CMT
Retinitis pigmentosa: Refsum disease, CMT.
Organomegaly (liver and spleen enlargement): POEMS, sarcoid, amyloidosis, AIDS, Tangier disease, SLE, RA (Felty's synd), alcohol toxicity.
Cranial nerve findings:
`Anosmia: Refsum disease, cobalamin deficiency, DM, hypothyroidism
Optic neuropathy: Refsum disease, CMT (+ SNHL)
Pupillary changes: GBS, CIDP, Sjogren's syndrome, selective postganglionic parasympathetic or more generalized autonomic neuropathy, paraneoplastic neuropathy, Adie syndrome
Facial sensory loss: MCTD, scleroderma, Sjogren's syndrome
Facial weakness: GBS, sarcoidosis, CIDP, Tangier disease, Gelosin amyloid related polyneuropathy.
Hoarseness of voice: CMT
Pearl: "If a patient who claims to be weak, cannot tell you about a specific activity that is problematic for him or her, then the existence of true muscle weakness remains doubtful unless it is subsequently corroborated by the physical examinations."
Pearl: "The extraocular muscles are rarely affected in motor neuron disease, the majority of polyneuropathies or acquired inflammatory myopathies."
Pearl: "If fatigue is the predominant feature, without objective signs such as weakness or elevated CK activity, it is unlikely to be a neuromuscular disease. Chronic fatigue syndrome is not neuromuscular disease."
Pearl: "Hickam’s dictum, or the absence of a singular parsimonious diagnosis, applies routinely in neuromuscular settings. Separate disease processes with distinct localizations can mimic or magnify symptoms of the peripheral nerve disease of interest and lead to a layering effect, where multiple neurologic localizations can contribute to the same clinical findings. For example, a patient presenting with a foot drop may have a simultaneous contribution from a focal fibular mononeuropathy and an L5 radiculopathy."
Pearl: "Cervical and lumbar radiculopathies can mimic focal mononeuropathies and, if bilateral, can also mimic polyneuropathies. Myopathies and neuromuscular junction disorders can mimic pure motor neuropathies. In the central nervous system, myelopathies can present with bilateral symmetric sensorimotor abnormalities, and a parafalcine brain lesion can present with bilateral lower extremity sensorimotor deficits. Many symptoms and signs of central nervous system disorders (eg, weakness, numbness, ataxia, dysautonomia) overlap with peripheral nerve disorders."
Pearl: "Layering of multiple peripheral nerve diseases can lead to electrodiagnostic test results that are difficult to interpret definitively. For example, a patient with a sensorimotor distal polyneuropathy may have their physical examination findings and electrodiagnostic testing results clouded by an incidental presence of a lumbar radiculopathy."
Pearl: "Patients with idiopathic sensorimotor polyneuropathy, bilateral carpal tunnel syndrome, lumbar stenosis, and dysautonomia should be considered for amyloid testing including genetic testing for hereditary transthyretin amyloidosis."
Pearl: "Idiopathic polyneuropathies. Despite thorough workup, 11% to 31% of polyneuropathy cases have no identifiable cause. Repeat laboratory testing generally does not yield additional information, provided genetic testing for inherited neuropathies are tested and are negative. Some of these cases have been classified as chronic idiopathic axonal polyneuropathy, which typically occurs between the ages of 50 to 60 years, and has a generally benign course. "
Clinical Vignette:
A 67-year-old right-handed man with a history of type 2 diabetes, hypertension, and lung cancer presented to the neurology office reporting hand weakness. About 1 year before presentation, the patient noticed hand grip weakness in the left hand. About 4 months later, he started to have similar symptoms in his right hand. He had noted muscle wasting in his hands and forearms. He denied sensory symptoms in his upper extremities. He had more remote symptoms of numbness and tingling in his feet, which he reported began soon after he received chemotherapy with cisplatin about 5 years earlier and overall had been stable without progression.
On examination, he had normal mental status and cranial nerve function. Examination of the upper extremities revealed weakness in bilateral finger abduction, which was worse on the left. He had moderate atrophy in the hypothenar eminence and first dorsal interossei bilaterally. Fasciculations were frequent in the bilateral first dorsal interossei. Strength examination of the lower extremities was normal. His muscle stretch reflexes were absent throughout. He had absent Babinski and Hoffman signs. Sensory examination of the feet revealed severe loss of vibration sensation and pinprick sensation up to the midshin. In the upper extremities, vibration testing of the second digit was normal, and pinprick testing revealed mild loss of sharp sensation in the right thumb and second digit.
The patient was evaluated via electrodiagnostic testing and laboratory testing, which led to a diagnosis of multifocal motor neuropathy with associated GM1 antibodies superimposed on a more long-standing length-dependent sensorimotor peripheral neuropathy and median neuropathy at the wrist.
COMMENT: This case illustrates the layering of clinical elements commonly encountered in peripheral nerve disease. Rather than classifying the onset and pace of progression of all symptoms together, the neurologist must parse the potential clinical entities and describe them accordingly. Although the patient had sensory neuropathy symptoms for many years in the feet, possibly from diabetes or chemotherapy (sensorimotor peripheral neuropathy), the most striking part of his presentation is the progressive hand weakness findings in the past year that may suggest a superimposed disorder (multifocal motor neuropathy). Although there is a combination of sensorimotor findings, the clinical details regarding the hand symptoms reveal a strong motor predominance with notable atrophy and muscle strength loss with only minimal associated sensory deficits. The pinprick loss in the right first and second digits represents an incidentally discovered carpal tunnel syndrome (median neuropathy at the wrist) that overlaps with his subacute motor-predominant hand symptoms.
Examples of neuromuscular syndrome within systemic diseases:
Neuropathy and diabetes mellitus and other metabolic diseases such as renal insufficiency.
Vasculitic neuropathy and polyarteritis nodosa: Wegener's disease and other diseases with systemic vasculitis.
Paraneoplastic neuropathy
Neuropathy and primary amyloidosis (associated with hematological malignancy)
Critical illness polyneuropathy
Critical illness myopathy
Dermatomyositis and polymyositis in the context of connective tissue disorder or malignancy
Myopathy and neuropathy and hypothyroidism
Thyrotoxic periodic paralysis
Hypokalemic paralysis in renal disorders (both in proximal and distal renal tubular acidosis).
Familial Gettleman syndrome, salt-losing to colopathy, with hypokalemia and hypomagnesemia may manifest with proximal weakness in young adults. Drug-induced neuropathy and myopathy.
Neuronopathies
Sensory polyneuropathies, which are caused by dysfunction of peripheral sensory nerve fibers, are a heterogeneous group of disorders that range from the common diabetic neuropathy to the rare sensory neuronopathies. The presenting symptoms, acuity, time course, severity, and subsequent morbidity vary and depend on the type of fiber that is affected and the underlying cause. Damage to small thinly myelinated and unmyelinated nerve fibers results in neuropathic pain, whereas damage to large myelinated sensory afferents results in proprioceptive deficits and ataxia. The causes of these disorders are diverse and include metabolic, toxic, infectious, inflammatory, autoimmune, and genetic conditions. Idiopathic sensory polyneuropathies are common although they should be considered a diagnosis of exclusion. The diagnostic evaluation involves electrophysiologic testing including nerve conduction studies, histopathologic analysis of nerve tissue, serum studies, and sometimes autonomic testing and cerebrospinal fluid analysis. The treatment of these diseases depends on the underlying cause and may include immunotherapy, mitigation of risk factors, symptomatic treatment, and gene therapy, such as the recently developed RNA interference and antisense oligonucleotide therapies for transthyretin familial amyloid polyneuropathy. Many of these disorders have no directed treatment, in which case management remains symptomatic and supportive. More research is needed into the underlying pathophysiology of nerve damage in these polyneuropathies to guide advances in treatment. Examples: Sjogren's syndrome, HIV infection, HTLV-1, Epstein-Barr virus, varicella zoster virus, measles, monoclonal gammopathies, paraneoplastic (anti-Hu syndrome), GBS variant, idiopathic sensory neurononpathy, nicotinic acid deficiency, vitamin E deficiency, riboflavin deficiency, and drugs such as carboplatin, doxorubicin, suramin, thallium, penicillin, and pyridoxine intoxication
Motor neuronopathy; ALS, SMA, poliomyelitis, WNV, monomelic anyotrophy
Peripheral Neuropathies: Sensory, motor, sensorimotor.
Myelinopathies
Axonopathies
Vasculopathies
Sensory neuronopathies: chronological and etiological classification.
Acute (onset from days to weeks):
ldiopathic, antibiotics, immune mediated, infections, pyridoxine overdose
Subacute (onset from weeks to months):
Primary Sjogren's syndrome, nutritional deficiency, toxic: pyridoxine overdose or cisplatin, methyl mercury, paraneoplastic, and infectious.
Chronic (onset from months to years): Idiopathic, idiopathic with gammopathy, vitamin E deficiency, hereditary (eg., Friedreich's ataxia, olivopontocerebellar atrophy.
Toxic neuropathies: Vincristine, cisplatin, vitamin B6 or pyridoxine toxicity, taxol.
Vit B6 when given in massive parenteral doses in grams over days can cause sensory neuronopathy and sensorimotor neuropathy resulting in gait ataxia, pseudoathetosis. Numbness, paresthesias, and impaired balance are present in most cases. If upper limbs are involved, there can be pseudoathetosis. Some patients will have pain, Lhermitte's sign and perioral numbness. Vibration, and position sensation are markedly affected. Touch, pain, and temperature also are abnormal in some patients. They are absent ankle jerks, and areflexia. Strength remains intact and patients do not have UMN signs. The site of lesion appears to be DRG. Lhermitte's sign implied some spinal cord involvement as well. Damage may be irreversible. Fasting serum level is needed to avoid spurious elevation.
Vitamin B12 deficiency as subacute combined degeneration
Sjogren's sensory neuronopathy
Autoimmune or postinfectious polyradiculopathy or sensory ganglionopathy (sensory form of GBS)
Paraneoplastic sensory neuronopathy associated with anti Hu antibody (remote effect of malignancy)
Immunosuppressant medications used to treat paraneoplastic sensory neuronopathies include corticosteroids, cyclophosphamide, sirolimus, and rituximab.
Immunomodulatory therapy includes IV immunoglobulin (IVIg) and plasma exchange. One published treatment strategy supports using highdose corticosteroids with or without IVIg followed by cyclophosphamide if the cancer is not found.
Symptomatic treatment consists of neuropathic pain medications
Distal Symmetric Purely Sensory or Sensory > Motor Neuropathies
Drug and toxic neuropathies, including alcohol
Diabetic distal symmetric polyneuropathy
Idiopathic
Vit B12, E, and thiamine deficiency
Although several different manifestations of peripheral neuropathy can be seen in patients with vitamin B12 deficiency, the most common form is a length-dependent sensorimotor neuropathy, with axonal as opposed to demyelinating features. The neuropathy is most commonly painless and can be associated with other signs of vitamin B12 deficiency, including cognitive impairment and myelopathy.
Toxic: Vit B6 toxicity, platinium based/taxol chemotherapy
Paraproteinemic neuropathies
Amyloidosis
Confluent vasculitis
SLE, Sjogren syndrome, celiac disease, autoimmune hepatitis, FGFR3-ab associated, paraneoplastic
Hereditary: Friedreich ataxia (Frataxin mutation and expansion of GAA repeats), Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (POLG mutations), Abetalipoproteinemia, vitamin E transporter deficiency (Vitamin E, low circulating β-lipoproteins, VLDL, LDL, chylomicrons, microsomal triglyceride transfer protein mutations), NARP (Neuropathy, ataxia, retinitis pigmentosa) from MT-ATP6 mutation
Infection: Leprosy, HIV, EBV, VZV, HTLV-1
CANVAS (Cerebellar ataxia, neuropathy, vestibular areflexia syndrome)
Disorders of Posterior Root Ganglia
Autoimmune: Autoimmune chronic active hepatitis, Paraneoplastic syndrome, Sjögren syndrome, Idiopathic
Infectious, Epstein–Barr virus infection, Human immunodeficiency virus infection, Rickettsia conorii infection, Varicella zoster infection.
Nutritional: Niacin deficiency, Pyridoxine deficiency, Vitamin E deficiency
Toxic: Antibiotic-related, Cisplatin, Pyridoxine, Thalidomide
Template:
Pins and needle sensation, burning sensation,
Pain and its ChLoRIDE-PP
Weakness, fatigue, muscle cramps, muscle twitching, muscle stiffness and trouble relaxing, gait and balance, falling or tripping, using assistive devices, chewing or swallowing difficulties, swallowing, with choking on liquids or solids, speech and voice difficulties,
Examples of functional abilities prior to symptoms and examples of functional abilities after symptom onset.
What are the things you were able to do before your symptoms started, that you are not able to do now?
Weight stability
Bladder and bowel dysfunction
Visual symptoms
Any history of similar complaints or problems in past?
Alcoholism?
Diabetes?
HIV?
Thyroid disease?
Exposure to chemotherapy agents?
Exposure to heavy metals or solvents?
Hepatitis B or C
Recent viral illnesses
New medications?
Other systemic symptoms?
History of back or neck trauma, back or neck surgeries?
History of travel, camping, tick-bites, food-related illness, nausea, vomiting, diarrhea, dysentery?
Any changes in medications, doses of medication?
Any changes in diet?
Family hx of neuropathy or other neurologic disease?
EMG:
Orthostatic lightheadedness
Syncope
Exertional intolerance?
Fatigue
Brain fog
Insomnia
Headache
Chest pressure
Heart palpitations
Shortness of breath
Abdominal pressure
Early satiety
Post-prandial nausea
Constipation
Diarrhea
Urinary urgency
Urinary frequency Vomiting of undigested food?
Erectile dysfunction and decreased libido in men
Vaginal dryness, clitoral insensitivity, dyspareunia, and loss of libido in women
Excessively sweating
Lack of sweating
Heat intolerance
Cold intolerance
Excessively dry eyes
Excessive dry mouth
Redness of feet and hands
Joint hypermobility
Joint dislocation
Hyperelastic skin
Food allergies
Anaphylaxis
Pruritus
Urticaria
Dermatographism
Onset, pace of progression, anatomic distribution and pattern, modalities affected, affected nerve fiber type, electrodiagnostic features, and associated clinical context.
Electrodiagnostic approach towards Polyneuropathy
The first step in the evaluation of a patient with polyneuropathy is to reduce the differential diagnosis to a smaller, more manageable number of possibilities. This usually can be accomplished by acquiring several critical pieces of information from the history, physical examination, and electrophysiologic studies.
Electrophysiologic studies can be used:
To confirm the presence of a polyneuropathy,
To assess its severity and pattern,
To determine whether motor, sensory, or a combination of fibers are involved, and, most importantly,
To assess whether the underlying pathophysiology is axonal loss or demyelination.
In cases in which a demyelinating polyneuropathy is found, further differentiation between an acquired and genetic condition can often be made. The information obtained from electrophysiologic testing, in conjunction with key pieces of clinical information, usually allows the differential diagnosis to be narrowed considerably so that further laboratory testing can be more appropriately applied and a final diagnosis reached. In addition, abnormalities in muscles and nerves on ultrasound can aid in the differential diagnosis of several selected peripheral neuropathies.
What Is the Temporal Course and Progression of Polyneuropathy (Acute, Subacute, Chronic; Progressive, Stepwise, Relapsing/Remitting)?
Temporal course and progression can be obtained by the history alone and often confirmed by electrophysiologic studies.
Most polyneuropathies are chronic, and their onset cannot be easily determined.
Acute polyneuropathies are notably less common: Guillain-Barré syndrome, Porphyria, Diphtheria, Drugs (e.g., dapsone, nitrofurantoin, vincristine), Toxins (e.g., arsenic, thallium, triorthocresylphosphate), Tick paralysis, and Vasculitis.
Among them, Guillain-Barré syndrome (GBS) (and its most common variant, acute inflammatory demyelinating polyneuropathy [AIDP]) is the most distinctive, with an onset over a few days or a few weeks at most. Similarly, most polyneuropathies are slowly progressive. Polyneuropathies that progress in a stepwise fashion are infrequent and are often associated with a mononeuropathy multiplex pattern. Likewise, the history of a relapsing/remitting course is distinctly unusual and suggests either an intermittent exposure/intoxication or a variant of chronic inflammatory demyelinating polyneuropathy (CIDP).
Which Fiber Types Are Involved (Motor, Sensory, Large or Small Sensory, Autonomic)?
The next step is to determine which fiber types are involved. This information is obtained primarily from the history and confirmed by physical examination and electrophysiologic tests.
Nerve fibers can be categorized either by the modality carried (motor, sensory, autonomic) or by fiber size. All motor fibers are large-diameter, myelinated fibers, whereas all autonomic fibers are small-diameter, mostly unmyelinated fibers. However, sensory fibers may be either large or small in diameter. Large sensory fibers mediate vibration, proprioception, and touch, whereas small sensory fibers convey pain and temperature sensations.
When nerve is diseased, it can react in a limited number of ways. Thus, many peripheral nerve disorders present with similar symptoms despite different etiologies. Symptoms and signs of nerve dysfunction result either from lack of function (negative symptoms and signs) or from abnormal function or over-functioning (positive symptoms and signs).
For example, anyone who has fallen asleep on his or her arm can remember the initial numbness or lack of feeling (negative symptoms), followed by intense pins-and-needles paresthesias (positive symptoms) as circulation is restored.
Characteristic positive or negative sensory symptoms and signs caused by diseased nerves help one recognize which fiber types are involved. Determining which fiber types are involved has important diagnostic implications.
Most polyneuropathies involve both sensory and motor fibers on electrophysiologic testing, even though, clinically, most distal axonal polyneuropathies exhibit sensory symptoms and findings long before the disease process becomes sufficiently severe to cause actual weakness. Patients with certain hereditary polyneuropathies (e.g., Charcot-Marie-Tooth [CMT] polyneuropathy) and conditions such as lead poisoning, porphyria, and GBS may exhibit predominantly motor symptoms and signs.
On the sensory side, pure sensory neuropathies are unusual and often suggest a primary process affecting the dorsal root ganglia. These sensory neuronopathies are quite rare and are characteristically seen acutely or subacutely as a paraneoplastic syndrome, postinfectious process, or associated with Sjögren syndrome or pyridoxine (B6) intoxication. Chronic sensory neuronopathies may be seen in the inherited sensory neuropathies and as a component of some inherited neurodegenerative conditions (e.g., Friedreich’s ataxia).
Large and small fibers are affected in most polyneuropathies. Only a few polyneuropathies preferentially affect small fibers. Manifestations include autonomic dysfunction and a distal sensory deficit, particularly for pin-prick, often associated with painful, burning dysesthesias.
Small-Fiber Peripheral Polyneuropathies: Diabetes, Amyloidosis (inherited and acquired), Toxins (especially alcohol), Drugs (e.g., ddI, ddC), Hypertriglyceridemia, Hereditary sensory neuropathies, Tangier disease, Fabry disease, Acquired immunodeficiency syndrome, Idiopathic (especially in the elderly).
It is essential to appreciate that routine NCSs assess only large myelinated fibers. A patient who has pure small-fiber polyneuropathy, with complete sparing of the large fibers, may have completely normal electrophysiologic studies. Conversely, large-fiber polyneuropathies always show abnormalities on electrophysiologic testing. Predominantly large-fiber polyneuropathies result in clinical sensory deficits (particularly for vibration and touch), weakness, and loss of tendon reflexes, with little or no autonomic and pain/temperature sensation loss.
What Is the Pattern of the Polyneuropathy (Distal Dying Back [Distal-to-Proximal Gradient], Short Nerves, Multiple Nerves; Symmetry, Asymmetry)?
The overall pattern of the polyneuropathy is determined largely based on the clinical examination and is supplemented and confirmed by electrophysiologic studies.
In most polyneuropathies, there is a distal-to-proximal gradient of symptoms and signs. Distal symptoms and findings occur in most polyneuropathies, in part indicating the frequency with which axonal loss is the underlying pathologic process. Most axonal polyneuropathies exhibit a distal-to-proximal, dying back pattern, reflecting that the chance of damage to a nerve is length-dependent. Thus, the longest nerves are affected first, resulting in a stocking-glove distribution of symptoms.
Patients initially develop numbness or weakness of the toes and feet, which then slowly progresses up the leg. When the process reaches the upper calf, the fingertips become involved as well, because the distance from the lumbosacral spinal cord to the upper calf is the same as that from the cervical spinal cord to the fingertips. Only rarely will polyneuropathies preferentially affect the shorter, more proximal nerves before the distal ones (e.g., in porphyria, proximal diabetic neuropathy, and some cases of inflammatory demyelinating polyneuropathy).
After determining whether a distal-to-proximal gradient is present, one should next assess the polyneuropathy for symmetry. Nearly all polyneuropathies are symmetric. The presence of any significant asymmetry is a key finding; it usually excludes a large number of toxic, metabolic, and genetic conditions that cause only a symmetric pattern.
Asymmetry implies the possibility of
A mononeuropathy multiplex pattern
A superimposed radiculopathy or entrapment neuropathy
A variant of CIDP.
NCSs and EMG frequently are useful in sorting out these possibilities.
The pattern of a mononeuropathy multiplex is one of the most important patterns to recognize and differentiate from the length-dependent, dying-back, axonal polyneuropathy. The clinical presentation is distinctive: there is an asymmetric, stepwise progression of individual cranial and/or peripheral neuropathies. Over time, a confluent pattern may develop, which may be difficult to distinguish from a generalized polyneuropathy. In most cases, the individual neuropathies are of named nerves (i.e., median, ulnar, peroneal, etc.) as opposed to small nerve twigs. Mononeuropathy multiplex has a limited differential diagnosis and most often occurs in the setting of vasculitis and vasculitic neuropathy. As each subsequent nerve is infarcted, pain develops (often severe), followed hours or days later by weakness and numbness in the nerve’s distribution.
Although other organ systems are often involved, the initial clinical presentation of systemic vasculitis may involve only the peripheral nervous system. Indeed, there are now well-recognized cases in which vasculitis remains confined to the peripheral nervous system. This is called non-systemic vasculitis neuropathy.
Vasculitis (e.g., polyarteritis nodosa, Churg-Strauss syndrome, Wegener’s syndrome, hypersensitivity, cryoglobulinemia, systemic lupus erythematosus, rheumatoid arthritis, Sjögren syndrome, chronic active hepatitis)
Diabetes
Inflammatory demyelinating polyneuropathy (Lewis-Sumner variant)
Multiple entrapments (hereditary and acquired)
Infection (e.g., Lyme, leprosy, human immunodeficiency virus)
Infiltration (e.g., granulomatous disease [sarcoid], neoplasm [lymphoma, leukemia])
What Is the Underlying Nerve Pathology (Axonal, Demyelinating, or Mixed)?
Pathologically, injury to nerves consists of two major processes: axonal loss or demyelination.
The vast majority of polyneuropathies are primarily axonal.
In demyelinating polyneuropathies, the initial injury to the nerves reflects damage to or dysfunction of the Schwann cells and the myelin sheaths. As a consequence of demyelination, conduction is impaired with marked slowing of conduction velocity or frank conduction block.
In establishing the differential diagnosis of a peripheral nerve disorder, the presence of demyelination is always a key finding. Demyelination may be demonstrated either by nerve biopsy and pathologic examination or, more easily, by electrophysiologic testing. When NCSs demonstrate a polyneuropathy to be predominantly demyelinating, the differential diagnosis is readily narrowed to a small group of disorders.
Is There a Family History of Polyneuropathy?
For any patient with a polyneuropathy, especially when the diagnosis is not clear, particular attention must be paid to family history. There are a large number of inherited polyneuropathies. Although for most of them, only symptomatic therapy is available, correct diagnosis is important for genetic counseling and prognosis and to avoid unnecessary or inappropriate further testing and treatment. Of course, this may change in the future as more genetic modifying treatments become available.
CMT neuropathy refers to a group of inherited disorders characterized by chronic motor and sensory polyneuropathy. CMT accounts for the majority of inherited polyneuropathies and, in many large series, represents a significant proportion of patients with difficult-to-diagnose polyneuropathies. Four major types of CMT are defined based on their inheritance and physiology: the demyelinating autosomal dominant form is CMT1; the axonal autosomal dominant form is CMT2; the autosomal recessive form, most of which are demyelinating, is CMT4; and the X-linked demyelinating form is CMTX.
Within each type, there are several subtypes based on the specific genetic defect. In contrast to CMT, there are a smaller group of inherited polyneuropathies associated with defects of metabolism that have been described. Most are extremely rare and are associated with other systemic abnormalities.
Inherited polyneuropathies may affect certain individuals so minimally or may progress so slowly over an individual’s lifetime that the person never seeks medical attention. Therefore, it is often beneficial to examine family members, both clinically and with NCSs and EMG, to help determine whether the underlying etiology of the patient’s polyneuropathy is genetic. Several clinical clues, however, suggest the possibility of an inherited polyneuropathy. Foot deformity (pes cavus, hammer toes, high arches). History of a long-standing polyneuropathy (many years and often decades). History of very slow progression. Few positive sensory symptoms. Family history of “polio,” “rheumatism,” “arthritis,” or other disorders that actually might have been inherited polyneuropathy.
Is There a History of Medical Illness or Are There Signs Suggesting a Medical Illness Associated With Polyneuropathy?
A careful history and general physical examination are essential in evaluating a patient with polyneuropathy.
Several medical conditions are strongly associated with polyneuropathy. Most prominent among them are diabetes and other endocrine disorders, cancer, connective tissue disorders, porphyria, vitamin and other deficiency states, and human immunodeficiency virus (HIV) infection.
Is There Any History of Occupational or Toxic Exposure to Agents Associated With Polyneuropathy?
Finally, it is always important to ask about occupational and exposure history.
Among drugs, most notable are cancer chemotherapeutic agents, which frequently result in polyneuropathy that is detectable either clinically or electrically.
In addition, a large number of prescription drugs, as well as over-the-counter medicines, can cause polyneuropathy. A careful review of all medicines is always important.
Asking about a patient’s occupational and recreational activities occasionally elicits a toxic source for the neuropathy.
One should always inquire about the patient’s use of alcohol, which is one of the most frequent causes of toxic polyneuropathy.
Preston and Shapiro.